Coronaviruses are a global public health risk, with three highly infectious species, including SARS-CoV-2, emerging in the last 20 years. New research by the University of Bristol has shown how an HIV drug could stop many ...
Dec 5, 2023
0
59
Across the 30 countries of the European Union and European Economic Area (EU/EEA), 22,995 new HIV diagnoses were reported in 2022. Almost every second new HIV diagnosis (49%, n=11,103) was among migrants, i.e., among people ...
Nov 30, 2023
0
0
The United Nations said Tuesday it is still possible to reach the "end of AIDS" by 2030—but only if communities and services on the ground are given the means.
Nov 28, 2023
0
0
People living with HIV may face hard choices when balancing their own health needs with caring for a pet, a study led by a University of Florida College of Public Health and Health Professions researcher finds.
Nov 1, 2023
0
0
Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for the type of drug that reduces a person's risk of contracting HIV.
Oct 16, 2023
0
1
HIV self-test kits were developed to make it easier for people to access HIV testing. However, our research team has found that many people who use self-test kits do not go on to receive needed HIV treatment or start preexposure ...
Oct 3, 2023
0
1
A new injectable solution that self-assembles into a gel under the right conditions could help manage HIV unlike any currently available methods, researchers have found.
Sep 25, 2023
0
14
Today, HIV can be managed with medical treatment. However, despite 40 years of intensive research, scientists have not yet succeeded in finding a cure for the disease. People with HIV experience a flare-up of the virus only ...
Sep 18, 2023
1
46
Lenacapavir, an injection, has been approved by the FDA for multi-drug resistant HIV.
Sep 1, 2023
0
23
The Global Fund announced Wednesday a deal with generic pharmaceutical manufacturers to significantly slash the price of a cutting-edge HIV drug, in a move it said would save lives.
Aug 30, 2023
0
3
